Introduction
============

PGCs (primordial germ cells) are the only cells in the body that undergo meiosis. Their developmental timeline is characterized by distinct cell cycle states that lead to the production of highly differentiated oocytes and spermatozoa. From initial specification at 7.25 dpc (days post coitum) in mice (Lawson and Hage, [@B27]; Saitou et al., [@B46]), a cluster of approx. 20 germ cells proliferate mitotically as they migrate to the genital ridge by 10.5--11.5 dpc (Chiquoine, [@B11]; Ginsburg et al., [@B20]; Ohinata et al., [@B42]). Here, they number approx. 25000 (Tam and Snow [@B57]; Donovan et al., [@B16]) and, in response to somatic cell cues, begin differentiation along the male (XY) or female (XX) pathway. XY germ cells enter G~1~/G~0~ arrest from 12.5 dpc, signifying commitment to the male pathway (Hilscher, [@B22]), while XX germ cells enter the first phase of meiosis from 13.5 dpc (Speed, [@B52]). G~1~/G~0~ arrest is completed by 14.5 dpc and maintained by the XY germ cells until after birth when they recommence several rounds of mitotic divisions before completing meiosis at the time of puberty (Setchell and Main, [@B48]; Western et al., [@B63]). XX germ cells enter meiosis in response to retinoic acid (Bowles et al., [@B9]; Koubova et al., [@B26]) and progress through to diplotene of meiosis I by 17.0 dpc--5 dpn (days post natum) (Borum, [@B8]; Speed, [@B52]). Meiosis then proceeds further as they mature into primordial follicles, but is not fully completed until fertilization (Pedersen and Peters, [@B43]; Gougeon, [@B21]).

Throughout all stages of germ cell development these cell cycle states are subject to tight regulation from the somatic cell environment. In addition to triggering the appropriate sex-specific cell cycle states in XY and XX germ cells, the somatic cells can also induce germ cell apoptosis in response to aberrant cell cycle regulation (McLaren, [@B33]; Coucouvanis et al., [@B12]; Nakatsuji and Chuma, [@B41]). Apoptosis is an effective mechanism for maintaining cellular integrity (Matsui, [@B30]), which is of high importance as germ cells are capable of acquiring 'stemness' despite their differentiated nature. In situations where apoptosis fails in the testis, germ cells can form CIS (carcinoma *in situ*) and TGCTs (testicular germ cell tumours) (Bartkova et al., [@B5]; Hoei-Hansen et al., [@B23]), which can be lethal or contribute to reduced fertility.

Despite the importance of germ cell cell cycle control for fertility, the exact machinery and regulatory mechanisms utilized have not yet been thoroughly investigated. Current knowledge about XY germ-cell G~1~/G~0~ arrest is limited to several candidate analyses and two knockout mouse models. Particularly, *p63*, a member of the p53 family, is expressed in G~1~/G~0~ arrested germ cells and the *p63*^−/−^ mouse model displays a significant increase in the number of germ cells by birth due to a decrease in gonocyte apoptosis (Petre-Lazar et al., [@B44]). PIN1 (peptidylprolyl isomerase 1) has been implicated in many aspects of the cell cycle, including progression, DNA replication and checkpoint control (Lu et al., [@B29]; Winkler et al., [@B65]), and XY germ cells in *Pin1*^−/−^ mutants displayed a prolonged cell cycle rate and an inability to enter G~1~/G~0~ arrest (Atchison et al., [@B1]). Additionally, activation of the CDK (cyclin-dependent kinase) inhibitors p15(INK4b), p16(INK4a) and p27(Kip1), as well as dephosphorylation of the RB1 (retinoblastoma 1) protein, has been identified during XY germ cell arrest (Western et al., [@B63]). Even though it has been hypothesized that germ cells employ a unique method of cell cycle control, these factors are all typical of somatic cell cell cycle control.

Cell cycle control common to both somatic and germ cells was also recently highlighted in a study of post-migratory, undifferentiated germ cells at 11.5 dpc, using a cell cycle array (Sorrentino et al., [@B51]). This study revealed germ cell control of G~1~-phase that was comparable with somatic cells, and included expression of *Ccnd3* (cyclin D3), *Rb1* and CDK inhibitors. Furthermore, it was evident that this population of germ cells was responsive to growth factor signalling and utilized cell cycle-regulated CDK inhibitor activity control in a similar way to the somatic cells analysed (Sorrentino et al., [@B51]).

In an analogous approach, we used a cell cycle array to identify the cell cycle machinery of XX and XY germ cells as they differentiate and enter their respective sex-specific cell cycle states prior to birth. In the present study, we discuss the known functions of the genes identified in our screen in relation to fetal germ cell cell cycle control and draw comparisons from postnatal development. Our results highlighted a common calcium-signalling pathway in both XX and XY germ cells, and identified extensive regulation of apoptosis within the XY germ cell population. Additionally we saw that G~1~/G~0~ arrest involved up-regulation of a RB family member and *p21*. Although our array did not detect meiosis-specific genes, we were able to identify the suppression of several mitotic genes in the XX germ cell population. Our results provide a comprehensive molecular description of cell cycle regulation of fetal germ cells as they undertake their sex-specific differentiation during development.

Results
=======

Germ cell purity and 12.5 versus 14.5 dpc XX and XY germ cell analysis
----------------------------------------------------------------------

In order to profile changes in cell cycle gene expression during sex differentiation, we isolated XY and XX germ cells from 12.5 and 14.5 dpc gonads using an antibody-based magnetic purification system. We optimized this purification technique and identified SSEA-1 (stage-specific embryonic antigen 1) as the most effective at 12.5 dpc, and E-cadherin for 14.5 dpc populations (data not shown). Using these antibodies we achieved a different level of purity for each time point and sex. Based on the expression level of germ cell- and somatic cell-specific genes ([Figure 1](#F1){ref-type="fig"}), along with visual assessment of AP (alkaline phosphatase) staining of the purified populations (ratio of AP-positive cells to AP-negative cells; results not shown), we determined the approximate purity as follows: 12.5 dpc XY \>60%, 12.5 dpc XX \>65%, 14.5 dpc XY \>75% and 14.5 dpc XX \>90%.

![Analysis of XY and XX isolated germ cell population purities\
12.5 and 14.5 dpc germ cell populations were assessed for gene expression of the germ cell marker *Mvh*, and the somatic cell markers *Sox9* (XY) and *Fst* (XX). qPCR analysis from purified populations normalized to 18S RNA. *n*=3, error bars represent S.E.M. Highest expression of *Mvh* was detected in all germ cell populations. Expression of *Sox9* was highest in the XY somatic cell populations, with greatest specificity at 14.5 dpc. Expression of *Fst* was also highest in the XX somatic cell populations, with greatest specificity at 14.5 dpc.](boc497i001){#F1}

Using cDNA generated from the isolated germ cell populations, we profiled the expression level of 112 cell cycle-related genes for each time point ([Figure 2](#F2){ref-type="fig"}A). Membrane hybridization represented three individual germ cell isolations for each sex and time point ([Figure 2](#F2){ref-type="fig"}B). Using these populations we were able to make four comparisons: XX versus XY germ cells at 12.5 and 14.5 dpc and 12.5 versus 14.5 dpc for XX and XY germ cells. Because microarray analysis is generally known to underestimate fold changes in gene expression (Dallas et al., [@B13]), we focused on fold differences greater than 1.3. This threshold has also been used in other microarray studies (McHale et al., [@B32]). Using these criteria, gene expression changes across the germ cell populations revealed both up- and down-regulation of genes across all phases of the cell cycle ([Table 1](#T1){ref-type="table"}). From each comparison we next validated a selection of genes using qPCR \[quantitative real-time RT--PCR (reverse transcription--PCR)\] ([Figure 3](#F3){ref-type="fig"}). Six out of nine genes analysed displayed a greater fold change than that detected by the array ([Table 2](#T2){ref-type="table"}), most likely reflecting the sensitivity of qPCR analysis relative to the microarray analysis (Dallas et al., [@B13]).

![Gene identities and germ cell-hybridized membranes of the cell cycle array\
(**A**) Gene identities as spotted on to a SuperArray Cell Cycle Array (OMM-020). Genes have been colour-coded into their respective phases of the cell cycle in which they function: regulation of the cell cycle, checkpoint and cell cycle arrest, negative regulation of the cell cycle, G~1~-phase and G~1~/S transition, S-phase and DNA replication, G~2~-phase and G~2~/M transition and M- phase. (**B**) Hybridized membranes from three separate collections of XX and XY germ cell populations at 12.5 and 14.5 dpc showing the exposure used to generate fold expression changes between samples.](boc497i002){#F2}

![Validation of significantly up- and down-regulated transcripts identified from 12.5 versus 14.5 dpc germ cell populations\
qPCR analysis from purified populations normalized to 18S RNA, *n*=3. (**A**) Increased fold expression of *Tnfs5ip*, *Rbl2* and *Camk2g* and decreased fold expression of *E2f6*, *Gas2* and *Cks1b* in XY 14.5 dpc populations relative to XY 12.5 dpc populations. (**B**) Increased fold expression of *Tnfs5ip*, *Camk2a* and *Camk2g* and decreased fold expression of *Rbl1*, *Dst* and *E2f6* in XX 14.5 dpc populations relative to XX 12.5 dpc populations. Gc, germ cell; Rel., relative.](boc497i003){#F3}

###### Fold induction of cell cycle genes expressed in 12.5 and 14.5 dpc XX and XY germ cell populations

  Gene symbol   Gene description                                                                                 GenBank® accession number   XY 14.5 versus 12.5   XX 14.5 versus 12.5   12.5 XY versus XX   12.5 XX versus XY   14.5 XY versus XX   14.5 XX versus XY
  ------------- ------------------------------------------------------------------------------------------------ --------------------------- --------------------- --------------------- ------------------- ------------------- ------------------- -------------------
  *Mcm6*        Minichromosome maintenance deficient 6                                                           NM_118567                   3.72                                                            1.69                                    
  *Camk2g*      Ca^2+^/calmodulin-dependent protein kinase II γ                                                  NM_178597                   3.52                  1.92                  1.4                                                         1.31
  *Tnfsf5ip1*   Tumour necrosis factor superfamily, member 5-induced protein 1                                   NM_134138                   2.79                  1.4                                                                               1.59
  *Nek3*        NIMA ([n]{.ul}ever [i]{.ul}n [m]{.ul}itosis in *[A]{.ul}spergillus nidulans*)-related kinase 3   NM_011848                   2.24                                        1.88                                                        
  *Ccne2*       Cyclin E2                                                                                        NM_009830                   1.99                                                                                                    1.68
  *Sfn*         Stratifin                                                                                        NM_018754                   1.85                                                                                                    
  *Cdk5rap1*    CDK5 regulatory subunit associated protein 1                                                     NM_025876                   1.84                                                                                                    
  *Cdkn1a*      Cyclin-dependent kinase inhibitor 1A (p21)                                                       NM_007669                   1.82                  1.29                                                                              1.34
  *Mdm2*        Transformed mouse 3T3 cell double minute 2                                                       NM_010786                   1.78                                                                                                    2.38
  *Nfatc1*      Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1                        NM_016791                   1.7                                                                                                     1.95
  *Cdk4*        Cyclin-dependent kinase 4                                                                        NM_009870                   1.64                                                                                                    1.62
  *Rbl2*        Retinoblastoma-like 2                                                                            NM_011250                   1.61                                        1.3                                                         
  *Cdk2*        Cyclin-dependent kinase 2                                                                        NM_016756                   1.58                                                                                                    1.79
  *Cdk5rap3*    CDK5 regulatory subunit associated protein 3                                                     NM_030248                   1.57                                                                                                    
  *Atm*         Ataxia telangiectasia mutated homologue                                                          NM_007499                   1.56                                        1.63                                                        
  *Msh2*        MutS homologue 2                                                                                 NM_008628                   1.51                                                                                                    2
  *Camk2a*      Ca^2+^/calmodulin-dependent protein kinase II α                                                  NM_077407                   1.5                   1.74                                      1.46                                    
  *Camk2b*      Ca^2+^/calmodulin-dependent protein kinase II β                                                  NM_007595                   1.5                   1.35                                      1.4                                     1.55
  *Camk2d*      Ca^2+^/calmodulin-dependent protein kinase II δ                                                  NM_023813                   1.49                                                                                                    1.39
  *Mcm4*        Minichromosome maintenance deficient 4 homologue                                                 NM_008565                   1.49                                                                                                    1.74
  *Shc1*        Src homology 2 domain-containing transforming protein C1                                         NM_011368                   1.46                  --14.11                                                                           25.33
  *Trp53*       Transformation related protein 53                                                                NM_011640                   1.45                                                                                                    1.44
  *Ccna1*       Cycin A1                                                                                         NM_007628                   1.39                                                                                                    
  *Pkd2*        Polycystic kidney disease 2                                                                      NM_008861                   1.37                                                                                                    1.54
  *Pcna*        Proliferating cell nuclear antigen                                                               NM_011045                   1.34                                                                                                    1.4
  *Trp63*       Transformation related protein 63                                                                NM_011641                   1.32                                                                                                    1.36
  *Ran*         RAN, member RAS oncogene family                                                                  NM_009391                   1.27                                                                                                    1.39
  *Pkd1*        Polycystic kidney disease 1                                                                      NM_013630                   1.25                  --2.92                                                                            3.96
  *Mtbp*        Mdm2, transformed 3T3 cell double minute p53-binding protein                                     NM_134092                   1.05                                                                                                    1.44
  *Rbl1*        Retinoblastoma-like 1                                                                            NM_011249                   1.04                  --1.62                                                                            1.75
  *Sesn3*       Sestrin 3                                                                                        NM_030261                   --1.21                --2.67                                                                            2.6
  *Cks1b*       CDC28 protein kinase 1b                                                                          NM_016904                   --1.53                                                                              1.32                
  *E2f6*        E2F transcription factor 6                                                                       NM_033270                   --1.63                --1.61                1.3                                                         
  *Gas2*        Growth arrest-specific 2                                                                         NM_008087                   --2.6                                                                               1.96                
  *Cdc25b*      Cell division cycle 25 homologue B                                                               NM_023117                                         --2.43                                                                            3.85
  *Dst*         Dystonin                                                                                         NM_134448                                         --1.32                                                                            2.42
  *Mre11a*      Meiotic recombination 11 homologue A                                                             NM_018567                                                                                   4.5                                     
  *Ppp23a*      Protein phosphatase 2 (formerly 2A), regulatory subunit B, α                                     XM_001005535                                                                                1.53                                    2.13
  *Rad9*        RAD9 homologue                                                                                   NM_011237                                                                                   1.32                                    
  *Ccnd1*       Cyclin D1                                                                                        NM_007631                                                                                                                           5.61
  *Prm2*        Protamine 2                                                                                      NM_008933                                                                                                                           2.13
  *Gas1*        Growth arrest-specific 1                                                                         NM_008086                                                                                                                           2.03
  *Wee1*        Wee 1 homologue                                                                                  NM_009516                                                                                                                           1.95
  *Mcm4*        Minichromosome maintenance deficient 4 homologue                                                 NM_008563                                                                                                                           1.74
  *Npm2*        Nucleophosmin/nucleoplasmin 2                                                                    NM_007892                                                                                                                           1.74
  *E2f5*        E2F transcription factor 5                                                                       NM_007595                                                                                                                           1.7

###### Comparison of gene fold changes detected in the microarray analysis and qPCR

               XY germ cells   XX germ cells            
  ------------ --------------- --------------- -------- --------
  *Rbl2*       1.61            1.84                     
  *Gas2*       --2.60          --1.49                   
  *Cks1b*      --1.530         --2.07                   
  *Tnfsf5ip*   2.79            1.86            1.40     2.51
  *Camk2g*     3.52            1.45            1.92     1.89
  *E2f6*       --2.16          --1.60          --1.61   --1.66
  *Camk2a*                                     1.74     2.07
  *Rbl1*                                       --1.62   --1.33
  *Dst*                                        --1.32   --3.48

Comparison of XX versus XY germ cells at 12.5 dpc identified very few genes with a fold difference greater than 1.3 between these populations, with only five and six genes up-regulated in the XX and XY germ cell populations respectively. This cell cycle expression profile is consistent with actively cycling germ cells in both sexes. Conversely, comparison of XX versus XY populations at 14.5 dpc highlighted a large number of genes more highly expressed in the XX germ cells (34 genes), as opposed to the XY germ cell population, which had only two genes up-regulated at this time. This result is indicative of a comparison between a population that is actively cycling (XX germ cells) and a population that has ceased cell division (XY germ cells), supporting the suitability of our isolation technique for this study.

Cell cycle analysis of 12.5 versus 14.5 dpc XY germ cells
---------------------------------------------------------

Germ cells in the XY gonad have been reported to enter G~1~/G~0~ arrest from 12.5 dpc onwards, and this arrest is complete for most of the germ cells by 14.5 dpc (Western et al., [@B63]). Consistent with this timeline, our analysis of 14.5 versus 12.5 dpc XY germ cell populations revealed that 26 genes were up-regulated and three genes were down-regulated at 14.5 dpc and showed enrichment in the G~1~-phase of the cell cycle ([Table 1](#T1){ref-type="table"}). Specifically, those genes up-regulated that were involved in G~1~/G~0~ arrest included the classic cell cycle-arrest genes *Rbl2* (retinoblastoma-like 2), CDK inhibitor p21 (*Cdkn1a*) and *Pkd2* (polycystic kidney disease-2). Genes involved in the G~1~-phase of the cell cycle included the CaMKII (Ca^2+^/calmodulin-dependent protein kinase II) subunits *Camk2a*, -*2b*, -*2d* and -*2g* in addition to *Nfatc1* (nuclear factor of activated T-cells-1). The G~1~-phase cyclins included *Ccna1* and *Ccne2* and CDKs *Cdk4* and *Cdk2*. Eight up-regulated genes involved in checkpoint control were *p53*, *p63*, *ATM* (ataxia telangiectasia mutated), *Mdm2* (murine double minute 2), encoding CDK5 subunits *Cdk5rap1* and *Cdk5rap3*, *Msh2* (MutS homologue 2) and *Shc1* (Src homology 2 domain-containing transforming protein C1).

Three genes involved in the S-phase of the cell cycle in the 14.5 dpc XY germ cell population included minichromosome maintenance genes *Mcm4* (minichromosome maintenance deficient 4), *Mcm6* and *Pcna* (proliferating-cell nuclear antigen). We identified only three genes involved in the G~2~/M-phase of the cell cycle, namely *Nek3* \[NIMA ([n]{.ul}ever [i]{.ul}n [m]{.ul}itosis in *[A]{.ul}spergillus nidulans*)-related kinase 3\], *Sfn* (Stratifin) and *Tnfs5ip* (tumour necrosis factor superfamily, member 5-induced protein 1) (*Clast3*). From our array we observed three genes that were down-regulated from 12.5 to 14.5 dpc in XY germ cells and these were involved in checkpoint control: CDK1 \[*Cks1* (CDC28 protein kinase 1)\], *Gas2* (growth arrest-specific-2) and the transcription factor *E2f6* ([Figure 4](#F4){ref-type="fig"}A).

![Functional gene groupings of significantly up- and down-regulated transcripts in XY and XX germ cell populations at 14.5 dpc relative to 12.5 dpc populations\
(**A**) A total of 13 genes involved in G~1~/G~0~ were up-regulated in XY 14.5 dpc populations. Seven genes up-regulated and three genes down-regulated were involved in restriction points and apoptosis. Three, two and one genes that are involved in S-phase, G~2~- and M-phase respectively were also up-regulated. (**B**) Three genes were up-regulated and three genes down-regulated that are involved in G~1~/G~0~ in the 14.5 dpc XX germ cell populations. Three genes involved in restriction points and apoptosis were down-regulated and one gene each involved in G~2~- and M-phase were up- and down-regulated respectively.](boc497i004){#F4}

Cell cycle analysis of 12.5 versus 14.5 dpc XX germ cells
---------------------------------------------------------

In contrast with XY germ cells in the testis, XX germ cells continue mitotic division after colonizing the ovary and enter meiosis from 13.5 dpc (Speed, [@B52]). Subsequent meiotic entry is less synchronous than that of XY germ cell G~1~/G~0~ arrest and XX germ cell entry into prophase I of meiosis is not completed until 17.0 dpc--5 dpn (Borum, [@B8]; Speed, [@B52]). As this array did not contain any meiosis-specific gene probes, we only observed four up-regulated and seven down-regulated genes in the XX cell population ([Table 1](#T1){ref-type="table"}). Up-regulated genes in the XX germ cells involved in G~1~-phase included three CaMKII subunits *Camk2a*, -*2b* and -*2g*. *Tnfsf5ip*, involved in G~2~/M-phase, was also up-regulated. Down-regulation of genes involved in G~0~ arrest included another member of the RB family *Rbl1* in addition to *Dst* (dystonin) and *Pkd1*. Those involved in checkpoint control and apoptosis in the XX germ cell population included *Shc1*, *E2f6* and *Sesn3* (Sestrin 3). Lastly, the G~2~/M-phase gene *Cdc25b* was also down-regulated in our analysis ([Figure 4](#F4){ref-type="fig"}B).

Discussion
==========

Germ cell sex differentiation, triggered by the somatic cell environment, heralds the beginning of a multitude of cell cycle changes that accommodate meiosis in these cells and lead to the differentiation of highly specialized gametes (oocytes or spermatozoa) (McLaren, [@B34]). Tight control of cell cycle progression is required at each stage to prevent aberrant proliferation that results in germ cell tumours or apoptosis that contribute to infertility (Hoei-Hansen et al., [@B23]). In order to gain insight into the cell cycle regulation that controls the earliest sex-specific differentiation during development, we employed a cDNA microarray to profile 112 cell cycle-related genes across XX and XY germ cells at 12.5 and 14.5 dpc.

XY germ cell G~1~-phase
-----------------------

XY germ cells are reported to enter G~1~/G~0~ arrest from 12.5 dpc in the developing testis and maintain this state until after birth (McLaren and Buehr, [@B36]; Western et al., [@B63]). From our array we identified multiple subunits (*Camk2a*, -*2b*, -*2d* and -*2g*) of CaMKII (Sheng et al., [@B49]; Matthews et al., [@B31]; Fukunaga and Miyamoto, [@B19]; Cai et al., [@B10];); however, as these subunits were also detected in the XX germ cell population, we suggest that calcium signalling has a survival role in these environments, as has been suggested previously (Yano et al., [@B68]; Bok et al., [@B7]), rather than signalling sex-specific responses for these cells. Interestingly, however, MAPK (mitogen-activated protein kinase) p38, which can activate calmodulin kinases and regulate proliferation, differentiation and cell survival, is activated specifically within the G~1~/G~0~ arrested germ cell population (K. Ewen, personal communication). These findings suggest that the calcium--MAPK pathway may be an active signalling mechanism used by the XY gonocytes.

We also identified the G~1~-phase cyclin *Ccna1* in XY germ cells. Interestingly, *Ccna1* is regarded as a germ cell-specific cyclin with expression almost entirely restricted to the spermatogonia of the adult testis (Sweeney et al., [@B54]) and *Ccna1*^−/−^ male mice are sterile (Wolgemuth et al., [@B66]). The CDKs *Ckd2* and *Cdk4* were also identified. Of these, *Ckd2* is required for the initiation of meiosis and male and female *Ckd2*^−/−^ animals are infertile (Barbacid et al., [@B3]).

XY germ cell G~1~/G~0~ arrest
-----------------------------

We have implicated several established cell cycle-arrest genes in XY germ cell G~1~/G~0~ arrest. Particularly, the RB family, to which *Rbl2* belongs, regulates cell growth, differentiation and apoptosis, and is expressed in a cell cycle-dependent manner throughout spermatogenesis (Yan et al., [@B67]; Toppari et al., [@B59]). Although *Rb1* itself was not included on this array, RB1 is translated and activated during XY G~1~/G~0~ arrest (Western et al., [@B63]), suggesting an important role for this family in XY germ cell biology. Additionally, the CDK inhibitor *p21* was up-regulated. p21 inhibits cell cycle progression by interacting with cyclin--CDK complexes, which induce apoptosis in adult testes in a p53-dependent manner (el-Deiry et al., [@B17]; Moreno et al., [@B39]). The *p21*^−/−^ model displays a somatic and germ cell proliferation defect in the adult testis (Deng et al., [@B14]); however, it is unclear whether this is a result of overproliferation or reduced apoptosis. The up-regulation of p21 during embryogenesis has also been detected by Western et al. ([@B63]) and further experiments are under way to determine whether p21 is also responsible for germ cell apoptosis or arrest at this stage.

XY germ cell apoptosis and checkpoint control mechanisms
--------------------------------------------------------

Our analysis revealed a robust control mechanism for apoptosis and checkpoint monitoring in the XY 14.5 dpc germ cell population. In particular, p53, p63 and ATM presumably act to reinforce germline integrity by apoptosis, of which p53 is the master regulator controlling DNA-damage and checkpoint failure-induced apoptosis in many cell types (reviewed by Meulmeester and Jochemsen, [@B38]). p53 is regulated by PI3K (phosphoinositide 3-kinase)/Akt (also called protein kinase B) (reviewed by Kimura et al., [@B24]) and TGF-β (transforming growth factor-β) signalling (reviewed by Sasai et al., [@B47]), the latter of which has been shown to play a role in germ cell survival in the embryonic testis (Memon et al., [@B37]). ATM is required in the pre-meiotic gonocyte stem cell population of the adult testis (Elson et al., [@B18]; Takubo et al., [@B56]); however, our analysis is the first report of *Atm* expression in XY fetal germ cells. *Mdm2* and *Msh2*, involved in p53-mediated apoptosis (Mostert et al., [@B40]) and replication error correction (Velasco et al., [@B62]) respectively were also up-regulated in XY germ cells. Consistent with an important role in maintaining germline integrity, mutations of both *Mdm2* and *Msh2* have been implicated in germ cell tumours (Velasco et al., [@B62]). Our identification of genes involved in postnatal tumours gives further support to the notion that fetal germ cell cell cycle control is crucial for their transformation into CIS and TGCTs (Bartkova et al., [@B4]; Hoei-Hansen et al., [@B23]).

XY germ cell progression past G~1~-phase
----------------------------------------

Whereas most of the genes identified in our array function within G~1~ and G~1~/G~0~ arrest, there was also an up-regulation of a small number of genes involved in the progression past G~1~-phase in which XY germ cells reside. It has been suggested by Moreno et al. ([@B39]) that the G~1~/G~0~ arrest of the germ cells is not a complete block in G~0~, but rather a slowing of G~1~-phase due to the observation that XY germ cells continue to increase in size during arrest and display high radiosensitivity, symptomatic of cycling cells (Moreno et al., [@B39]). Our analyses lend some support to this notion at the level of transcription. Indeed, three genes involved in S-phase were expressed in the 14.5 dpc XY germ cell population. Minichromosome maintenance genes *Mcm4*, *Mcm6* and *Pcna* gene products are involved in DNA replication (Swiech et al., [@B55]) and mismatch repair (Stone et al., [@B53]) respectively. Additionally, *Tnfs5ip* (*Clast3*) and *Nek3*, involved in later progression of the cell cycle (Tanaka and Nigg, [@B58]; Bahar et al., [@B2]), were also identified in our array.

Suppression of meiosis in XY germ cells
---------------------------------------

In contrast with XX germ cells, XY gonocytes do not enter meiosis until puberty (Setchell and Main, [@B48]). Appropriately, we observed the down-regulation of several genes involved in checkpoint control and suppression of germ cell-specific genes in XY germ cells. These included *Cks1*, which encodes a CDK that modulates cell cycle progression through the G~1~/S checkpoint, which is required for progression of meiosis in the adult testis. Accordingly, *Cks1*^−/−^ mutants display arrested spermatocytes in metaphase I of meiosis (Donovan and Reed, [@B15]), suggesting that fetal germ cells suppress this transcript that is required for the later stages of meiosis. Lastly, *E2f6*, which encodes a unique E2F member that is known to suppress XY germ cell-specific genes (Pohlers et al., [@B45]), was also appropriately down-regulated in XY germ cells.

Down-regulation of mitotic genes in XX germ cells
-------------------------------------------------

XX germ cells begin non-synchronous entry into prophase I of meiosis from 13.5 dpc onwards (McLaren, [@B35]). Therefore, using the mitotic cell cycle array employed in the present study, we did not detect any genes associated with meiosis; however, the down-regulation of several mitotic genes was identified. In particular, another member of the RB family, *Rbl1*, was down-regulated in XX germ cells, reinforcing the sex-specific expression of this family. Suppression of apoptotic genes was also apparent, with down-regulation of *Dst* and *Pkd1* (van Adelsberg, [@B61]; Bilyy et al., [@B6]), as well as *Sesn3*, which is responsive to p53 activation during apoptosis induction (Kopnin et al., [@B25]). Suppression of apoptotic genes at this time point fits with reported oocyte apoptosis that occurs at 13.5 dpc, and again from 15.5 to 17.5 dpc in the ovary (Coucouvanis et al., [@B12]). *Cdc25b*, also down-regulated in XX germ cells, encodes a phosphatase required to activate CDKs for cell cycle progression. In the adult ovary, this phosphatase has been shown to be essential for CDK1 activation during the resumption of meiosis past prophase I (Lincoln et al., [@B28]; Solc et al., [@B50]).

Conclusions
-----------

Our cell cycle gene expression analysis has highlighted several important cell cycle mechanisms utilized by XY and XX germ cells during the crucial time of sex differentiation in the developing gonads. In particularly, apoptosis regulation is apparent for both populations, along with calcium/calmodulin involvement, presumably for cell survival. The present study has provided a solid basis for the future investigation of both well- and little-known cell cycle genes in the regulation of sex-specific differentiation of fetal germ cells. Investigation into the expression of some of these newly identified genes in cases of TGCTs may provide further insight into the regulation of these highly specialized cells in cases of aberrant cell cycle control. Particular focus should surround the regulation of the RB family, p21, p53 and ATM in XY germ cells. Finally, regulation of *Dst* and *Pkd1* in addition to *Cdc25b* in the XX germ cells may shed light on the regulation of meiosis triggered by retinoic acid and other unidentified somatic factors.

Experimental
============

MiniMACS germ cell isolation
----------------------------

Germ cells were isolated from CD1 mouse embryo gonads dissected in ice-cold PBS at 12.5 and 14.5 dpc with mesonephros removed. Gonads were rinsed twice in Gibco cell dissociation buffer (13151-014; Invitrogen) and incubated with agitation in the dissociation buffer for 5 min at 37°C before dissociation using a 21G needle. Dissociated cells were diluted to 1.5 ml with MACS buffer (PBS containing 2 mM EDTA and 0.5% BSA) and centrifuged at 600 ***g*** at 4°C for 10 min. Pelleted cells were resuspended in 1:50 dilution of mouse anti-human SSEA-1 antibody (12.5 dpc; Santa Cruz Biotechnology) or rat anti-mouse E-cadherin antibody (14.5 dpc; Santa Cruz Biotechnology) in MACS buffer and incubated with agitation at 4°C for 45 min. Cells were then washed twice with MACS buffer by centrifugation and incubated in 1:5 dilution of rabbit anti-mouse IgG magnetic beads (SSEA-1;130-047-102; Miltenyi Biotec) or goat anti-rat IgG magnetic beads (E-cadherin; 130-048-501; Miltenyi Biotec) in MACS buffer with agitation at 4°C for 15 min. Cells were then washed twice with MACS buffer by centrifugation, resuspended in 1.5 ml of MACS buffer and applied to a presoaked MiniMACS column (130-042-201; Miltenyi Biotec) on a magnetic backing. Somatic cells were eluted with 3 ml of MACS buffer and the column was then removed from the magnetic backing and germ cells were eluted in 3 ml of MACS buffer. Purified germ cells were then either centrifuged at 16200 ***g*** for 1 min for immediate RNA isolation, or pelleted at 600 ***g*** for 10 min before staining for AP. Purity of the germ cell population was determined using both AP staining and qPCR analysis for expression of the germ cell marker *Mvh* (mouse vasa homologue) (Saitou et al., [@B46]) and somatic cell markers *Sox9* \[Sry-related HMG (high-mobility group) box protein 9\] (XY) (Wilhelm et al., [@B64]) and *Fst* (follistatin) (XX) (Vainio et al., [@B60]).

cDNA array
----------

Total RNA was isolated from purified germ cells using the ArrayGrade™ total RNA isolation kit (GA-013; SuperArray) as per the manufacturer\'s instructions. RNA quality was determined by spectroscopy at 260 and 280 nm using a Nanodrop (Nanodrop Technologies). Total RNA (1 μg) was amplified and labelled with the biotin TrueLabeling-AMP™ 2.0 system (GA-030; SuperArray) as per the manufacturer\'s instructions using Biotin-16-UTP (11388908910; Roche Applied Science). The commercial GEArray membranes (Oligo GEArray DNA Microarray: Mouse Cell Cycle Q Series; OMM-020; Superarray; www.SABiosciences.com/ArrayList.php) were prehybridized for 8 h at 60°C and hybridized with cRNA target samples overnight at 60 °C. Membranes were then washed with 2× SSC (1× SSC is 0.15 M NaCl/0.015 M sodium citrate) and 1% SDS and then in 0.1× SSC and 0.5% SDS at 60°C for exactly 15 min. Chemiluminescent detection was performed using AP-conjugated streptavidin and CDP-Star chemiluminescent substrate. Membranes were then exposed to an X-ray film (Fuji Photo Film).

cDNA array analysis
-------------------

A Hewlett--Packard ScanJet scanner was used to scan the signal for each array membrane. The signal intensity for each probe was analysed using the GEArray Analysis Suite. The total background for each membrane was subtracted from the total average value of each tetraspot for each cDNA sample. This value was normalized to the GAPDH (glyceraldehyde-3-phosphate dehydrogenase) signal control on each membrane. Transcript levels were then compared between arrays to identify the genes up- and down-regulated in each sample.

qPCR
----

Specific genes identified as being up- or down-regulated were measured on at least three independent cDNA samples using qPCR. Then 12.5 and 14.5 dpc XX and XY germ cells were isolated as described above and total RNA from each collection was isolated using a Micro RNA kit (Qiagen) as per the manufacturer\'s instructions including the optional DNaseI step. cDNA was synthesized from 1 μg of RNA by reverse transcription (Superscript III; Invitrogen) using random primers (Promega) according to the manufacturer\'s instructions. The ABIPrism-7000 Sequence Detector System was used to analyse relative cDNA levels. Primers were designed for each mRNA using the Universal Probe library tool (<https://www.roche-applied-science.com/sis/rtpcr/upl/adc.jsp>) (see Supplementary Table S1 at <http://www.biolcell.org/boc/101/boc1010587add.htm>). All qPCR experiments were performed in triplicate and repeated on three separate biological germ cell collections representing four pooled litters and results are represented as means±S.E.M. Briefly, samples were analysed in 25 μl reactions containing 1 μl of cDNA prepared as described above, SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, U.S.A.) and 1 μl of each forward and reverse primer (3.75 μM). Cycling conditions used an initial 10 min step at 95°C followed by 40 cycles of 95°C for 15 s and 60°C for 1 min in a two-step thermal cycle. Dissociation curves were analysed for each primer set to verify the amplification of a single product and cDNA samples were normalized against 18S rRNA using the 2^▵▵−*Ct*^ method (*C*~*t*~ is threshold cycle value).

Online data
===========
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